Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications

Area of Science:

• Oncology
• Biomedical Imaging
• Molecular Biology

Background:

• Molecular imaging enables in vivo visualization of cancer progression based on disease mechanisms.
• Optical imaging offers advantages for real-time cancer detection, especially in epithelial tissues, using visible to near-infrared light.
• Targeted ligands and fluorescence labeling enhance molecular specificity and image contrast.

Purpose of the Study:

• To review the clinical utility of molecular imaging for early cancer detection.
• To highlight the role of targeted ligands and optical methods in improving cancer visualization.
• To discuss the potential of molecular imaging in guiding biopsies, surgical resection, and therapy selection.

Main Methods:

• Utilizing a broad spectral range of light (visible to near-infrared) for optical imaging.
• Developing targeted ligands (small molecules, peptides, antibodies, etc.) for molecular specificity.
• Employing fluorescence labeling for high image contrast.

Main Results:

• Molecular imaging facilitates early detection and localization of suspicious lesions.
• This methodology aids in guiding tissue biopsy and surgical procedures.
• Visualizing molecular expression patterns can inform therapeutic choices and monitor treatment efficacy.

Conclusions:

• Molecular imaging is a clinically valuable tool for early cancer detection and management.
• Targeted optical imaging agents are advancing towards clinical translation for various human cancers.
• This approach supports personalized medicine by enabling precise diagnosis and treatment monitoring.